Mismatch for the minor histocompatibility antigen HA-2 and GVHD occurrence in HLA-A*0201-positive Tunisian recipients of HSCs

Immunological Investigations
M H SellamiS Hmida

Abstract

Graft-versus-Host disease (GVHD) has been widely linked to immunogenetic causes such as disparity between the recipient and its HLA geno-identical donor for some Non-HLA antigens called minor histocompatibility antigens (MiHAgs). HA-2 is one of potential human MiHAgs but its effect on the GVHD occurrence remains not clear. In order to examine such association in the Tunisian cohort of HSCs recipients, we performed a retrospective study on patients who received an HLA-identical HSCT between 2000 and 2009. The study was performed on 60 HLA-A2-positive patients who had received a haematopoietic stem cell transplant from an HLA-identical sibling. All patients received cyclosporine A and/or methotrexate for GVHD prophylaxis. HA-2 genotyping assay was performed with SSP-PCR method and HLA-A*0201 positive samples were identified mainly with Luminex HLA-Typing method. Luminex HLA-Typing assay showed that only 53 cases were positives for the HLA-A*0201 allele. Among these cases, only 3 pairs were mismatched for the MiHAg HA-2. Acute GVHD occurred in 01 HA-2-mismatched pair while chronic GVHD was detected in 02 disparate couples. Univariate and multivariate analyses showed that MiHAg HA-2 disparity does not have any significant effect on...Continue Reading

References

Feb 1, 1996·The New England Journal of Medicine·E BeharF C Grumet
Sep 7, 2001·The Journal of Immunology : Official Journal of the American Association of Immunologists·R A PierceV H Engelhard
Jul 24, 2002·Tissue Antigens·M WilkeE Goulmy
Sep 10, 2002·Transplant Immunology·E SimpsonP J Dyson
Sep 10, 2003·Experimental Hematology·J H Frederik FalkenburgRoel Willemze
Mar 27, 2007·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Kevin SheKirk R Schultz
Apr 24, 2007·Best Practice & Research. Clinical Haematology·Lothar HambachEls Goulmy
Sep 29, 2007·Translational Research : the Journal of Laboratory and Clinical Medicine·Yaping SunPavan Reddy
May 28, 2008·Best Practice & Research. Clinical Haematology·Tomomi ToubaiPavan Reddy
Jan 29, 2009·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·John G Gribben
Mar 14, 2009·Lancet·James L M FerraraErnst Holler
Jun 23, 2009·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Stephen SpellmanThomas M Ellis
Feb 9, 2010·Tissue Antigens·M H SellamiS Hmida

❮ Previous
Next ❯

Citations

Oct 9, 2014·Immunological Investigations·Youssef Mohamed Mosaad

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.